Carbapenemase Producing Gram-Negative Bacteria in Tunisia: History of Thirteen Years of Challenge

References

• Klein E, Van Boeckel T, Martinez E, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018;115(15):E3463–E3470. doi:10.1073/pnas.171729511529581252
   PubMed Web of Science ®Google Scholar
• Mölstad S, Löfmark S, Carlin K, et al. Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance. Bull World Health Organ. 2017;95(11):764–773. doi:10.2471/BLT.16.18437429147057
   PubMed Web of Science ®Google Scholar
• Pulcini C, Gyssens I. How to educate prescribers in antimicrobial stewardship practices. Virulence. 2013;4(2):192–202. doi:10.4161/viru.2370623361336
   PubMed Web of Science ®Google Scholar
• Georgopapadakou N. Penicillin-binding proteins and bacterial resistance to beta-lactams. Antimicrob Agents Chemother. 1993;37(10):2045–2053. doi:10.1128/AAC.37.10.20458257121
   PubMed Web of Science ®Google Scholar
• Poole K. Resistance to β-lactam antibiotics. Cell Mol Life Sci. 2004;61(17):2200–2223. doi:10.1007/s00018-004-4060-915338052
   PubMed Web of Science ®Google Scholar
• Meek R, Vyas H, Piddock L. Nonmedical uses of antibiotics: time to restrict their use? PLoS Biol. 2015;13(10):e1002266. doi:10.1371/journal.pbio.100226626444324
   PubMed Web of Science ®Google Scholar
• Founou L, Founou R, Essack S. Antibiotic resistance in the food chain: a developing country-perspective. Front Microbiol. 2016;7:1881.27933044
   PubMed Web of Science ®Google Scholar
• Hawkey P, Livermore D. Carbapenem antibiotics for serious infections. BMJ. 2012;344:e3236. doi:10.1136/bmj.e323622654063
   PubMed Web of Science ®Google Scholar
• Walsh T. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents. 2010;36:S8–S14. doi:10.1016/S0924-8579(10)70004-2
   PubMed Web of Science ®Google Scholar
• Logan L, Weinstein R. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215(suppl_1):S28–S36. doi:10.1093/infdis/jiw28228375512
   PubMed Web of Science ®Google Scholar
• Mugnier P, Poirel L, Naas T, et al. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis. 2010;16(1):35–40.20031040
   PubMed Web of Science ®Google Scholar
• Ktari S, Arlet G, Mnif B, et al. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-β-lactamase, CTX-M-15 extended-spectrum β-lactamase, and CMY-4 AmpC β-lactamase in a Tunisian university hospital. Antimicrob Agents Chemother. 2006;50(12):4198–4201. doi:10.1128/AAC.00663-0617015633
   PubMed Web of Science ®Google Scholar
• Berrazeg M, Diene S, Medjahed L, et al. New Delhi Metallo-beta-lactamase around the world: an eReview using Google Maps. Euro Surveill. 2014;19(20):pii=20809.
   Google Scholar
• Battikh H, Harchay C, Dekhili A, et al. Clonal spread of colistin-resistant Klebsiella pneumoniae coproducing KPC and VIM carbapenemases in neonates at a Tunisian University Hospital. Microb Drug Resist. 2017;23(4):468–472. doi:10.1089/mdr.2016.017527802107
   PubMed Web of Science ®Google Scholar
• Ben Tanfous F, Alonso CA, Achour W, Ruiz-Ripa L, Torres C, Ben Hassen A. First description of KPC-2-producing Escherichia coli and ST15 OXA-48-positive Klebsiella pneumoniae in Tunisia. Microb Drug Resist. 2017;23(3):365–375. doi:10.1089/mdr.2016.009027754776
   PubMed Web of Science ®Google Scholar
• Yigit H, Queenan A, Anderson G, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151–1161. doi:10.1128/AAC.45.4.1151-1161.200111257029
   PubMed Web of Science ®Google Scholar
• Grundmann H, Glasner C, Albiger B, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis. 2017;17(2):153–163. doi:10.1016/S1473-3099(16)30257-227866944
   PubMed Web of Science ®Google Scholar
• Robledo I, Aquino E, Vázquez G. Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico. Antimicrob Agents Chemother. 2011;55(6):2968–2970. doi:10.1128/AAC.01633-1021444702
   PubMed Web of Science ®Google Scholar
• Manenzhe R, Zar H, Nicol M, et al. The spread of carbapenemase-producing bacteria in Africa: a systematic review. J Antimicrob Chemother. 2015;70(1):23–40. doi:10.1093/jac/dku35625261423
   PubMed Web of Science ®Google Scholar
• Chouchani C, Marrakchi R, Ferchichi L, et al. VIM and IMP metallo‐β‐lactamases and other extended‐spectrum β‐lactamases in Escherichia coli and Klebsiella pneumoniae from environmental samples in a Tunisian hospital. APMIS. 2011;119(10):725–732. doi:10.1111/j.1600-0463.2011.02793.x21917010
   PubMed Web of Science ®Google Scholar
• Chouchani C, Marrakchi R, Henriques I, et al. Occurrence of IMP-8, IMP-10, and IMP-13 metallo-β-lactamases located on class 1 integrons and other extended-spectrum β-lactamases in bacterial isolates from Tunisian rivers. Scand J Infect Dis. 2013;45(2):95–103. doi:10.3109/00365548.2012.71771222992193
   PubMed Web of Science ®Google Scholar
• Dziri O, Alonso CA, Dziri R, et al. Metallo-β-lactamases and class D carbapenemases in south-east Tunisia: implication of mobile genetic elements in their dissemination. Int J Antimicrob Agents. 2018;52(6):871–877. doi:10.1016/j.ijantimicag.2018.06.00229909172
   PubMed Web of Science ®Google Scholar
• Ben Nasr A, Decré D, Compain F, et al. Emergence of NDM-1 in association with OXA-48 in Klebsiella pneumoniae from Tunisia. Antimicrob Agents Chemother. 2013;57(8):4089–4090. doi:10.1128/AAC.00536-1323752514
   PubMed Web of Science ®Google Scholar
• Messaoudi A, Haenni M, Mansour W, et al. ST147 NDM-1-producing Klebsiella pneumoniae spread in two Tunisian hospitals. J Antimicrob Chemother. 2017;72(1):315–316. doi:10.1093/jac/dkw40127659734
   PubMed Web of Science ®Google Scholar
• Jaidane N, Naas T, Oueslati S, et al. Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia. Int J Antimicrob Agents. 2018;52(6):916–921. doi:10.1016/j.ijantimicag.2018.05.01729857033
   PubMed Web of Science ®Google Scholar
• Kanzari L, Ferjani S, Saidani M, et al. First report of extensively-drug-resistant Proteus mirabilis isolate carrying plasmid-mediated blaNDM-1 in a Tunisian intensive care unit. Int J Antimicrob Agents. 2018;52(6):906–909. doi:10.1016/j.ijantimicag.2018.06.00929958975
   PubMedGoogle Scholar
• Potron A, Poirel L, Rondinaud E, et al. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill. 2013;18(31):pii=20549. doi:10.2807/1560-7917.ES2013.18.31.20549
   Google Scholar
• Evans BA, Amyes SGB. OXA β-Lactamases. Clin Microbial Rev. 2014;27(2):241–263. doi:10.1128/CMR.00117-13
   PubMed Web of Science ®Google Scholar
• Nasri E, Subirats J, Sànchez-Melsió A, et al. Abundance of carbapenemase genes (blaKPC, blaNDM and blaOXA-48) in wastewater effluents from Tunisian hospitals. Environ Pollut. 2017;229:371–374. doi:10.1016/j.envpol.2017.05.09528614760
   PubMedGoogle Scholar
• Khan F, Söderquist B, Jass J. Prevalence and diversity of antibiotic resistance genes in Swedish aquatic environments impacted by household and hospital wastewater. Front Microbiol. 2019;10:688.31019498
   PubMed Web of Science ®Google Scholar
• Mani Y, Mansour W, Mammeri H, et al. KPC-3-producing ST167 Escherichia coli from mussels bought at a retail market in Tunisia. J Antimicrob Chemother. 2017;72(8):2403–2404. doi:10.1093/jac/dkx12428472479
   PubMed Web of Science ®Google Scholar
• Mani Y, Mansour W, Lupo A, et al. Spread of blaCTX-M-15-producing Enterobacteriaceae and OXA-23-producing Acinetobacter baumannii sequence type 2 in Tunisian seafood. Antimicrob Agents Chemother. 2018;62(9):e00727–18. doi:10.1128/AAC.00727-1829967023
   PubMedGoogle Scholar
• Brahmi S, Touati A, Cadière A, et al. First description of two sequence type 2 Acinetobacter baumannii isolates carrying OXA-23 carbapenemase in Pagellus acarne fished from the Mediterranean Sea near Bejaia, Algeria. Antimicrob Agents Chemother. 2016;60(4):2513–2515.26787693
   PubMed Web of Science ®Google Scholar
• Lien L, Hoa N, Chuc N, et al. Antibiotics in wastewater of a rural and an urban hospital before and after wastewater treatment, and the relationship with antibiotic use—a one year study from Vietnam. Int J Environ Res Public Health. 2016;13(6):pii=E588. doi:10.3390/ijerph13060588
   Web of Science ®Google Scholar
• Tindall BJ, Sutton G, Garrity GM. Enterobacter aerogenes Hormaeche and Edwards 1960 (Approved Lists 1980) and Klebsiella mobilis Bascomb et al. 1971 (Approved Lists 1980) share the same nomenclatural type (ATCC 13048) on the Approved Lists and are homotypic synonyms, with consequences for the name Klebsiella mobilis Bascomb et al. 1971 (Approved Lists 1980). Int J Syst Evol Microbiol. 2017;67(2):502–504.27902205
   PubMed Web of Science ®Google Scholar
• Diene S, Rolain J. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2014;20(9):831–838.24766097
   PubMed Web of Science ®Google Scholar
• Cuzon G, Naas T, Nordmann P. Functional characterization of Tn4401, a Tn3-based transposon involved in blaKPC gene mobilization. Antimicrob Agents Chemother. 2011;55(11):5370–5373.21844325
   PubMed Web of Science ®Google Scholar
• Hammami S, Gautier V, Ghozzi R, et al. Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin Microbiol Infect. 2010;16(2):189–193. doi:10.1111/j.1469-0691.2009.03023.x19686278
   PubMed Web of Science ®Google Scholar
• Mansour W, Poirel L, Bettaieb D, et al. Metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia. Diagn Microbiol Infect Dis. 2009;64(4):458–461.19631102
   PubMed Web of Science ®Google Scholar
• Cheikh H, Domingues S, Silveira E, et al. Molecular characterization of carbapenemases of clinical Acinetobacter baumannii–calcoaceticus complex isolates from a University Hospital in Tunisia. 3 Biotech. 2018;8(7):297.
   Google Scholar
• Wailan A, Paterson D. The spread and acquisition of NDM-1: a multifactorial problem. Expert Rev Anti Infect Ther. 2014;12(1):91–115.24308710
   PubMed Web of Science ®Google Scholar
• Charfi K, Mansour W, Khalifa A, et al. Emergence of OXA-204 β-lactamase in Tunisia. Diagn Microbiol Infect Dis. 2015;82(4):314–317. doi:10.1016/j.diagmicrobio.2015.04.00326001616
   PubMed Web of Science ®Google Scholar
• Mansour W, Haenni M, Saras E, et al. Outbreak of colistin-resistant carbapenemase-producing Klebsiella pneumoniae in Tunisia. J Glob Antimicrob Resist. 2017;10:88–94. doi:10.1016/j.jgar.2017.03.01728711559
   PubMed Web of Science ®Google Scholar
• Charfi-Kessis K, Mansour W, Ben Haj Khalifa A, et al. Multidrug-resistant Acinetobacter baumannii strains carrying the blaOXA-23 and the blaGES-11 genes in a neonatology center in Tunisia. Microb Pathog. 2014;74:20–24. doi:10.1016/j.micpath.2014.07.00325057763
   PubMedGoogle Scholar
• Poirel L, Mansour W, Bouallegue O, et al. Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97. Antimicrob Agents Chemother. 2008;52(5):1613–1617. doi:10.1128/AAC.00978-0718299404
   PubMed Web of Science ®Google Scholar
• Lahlaoui H, Bonnin R, Moussa M, et al. First report of OXA-232-producing Klebsiella pneumoniae strains in Tunisia. Diagn Microbiol Infect Dis. 2017;88(2):195–197.28341097
   PubMed Web of Science ®Google Scholar
• Maamar E, Ferjani S, Jendoubi A, et al. High prevalence of gut microbiota colonization with broad-spectrum cephalosporin resistant Enterobacteriaceae in a Tunisian intensive care unit. Front Microbiol. 2016;7:1859. doi:10.3389/fmicb.2016.0185927965626
   PubMed Web of Science ®Google Scholar
• Fritzenwanker M, Imirzalioglu C, Herold S, et al. Treatment options for carbapenem-resistant Gram-negative infections. Dtsch Arztbl Int. 2018;115(20–21):345–352.
   PubMed Web of Science ®Google Scholar
• Lee C, Lee J, Park K, et al. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol. 2016;7:895.27379038
   PubMed Web of Science ®Google Scholar
• Qin S, Qi H, Zhang Q, et al. Emergence of extensively drug-resistant Proteus mirabilis harboring a conjugative NDM-1 plasmid and a novel Salmonella genomic island 1 variant, SGI1-Z. Antimicrob Agents Chemother. 2015;59(10):6601–6604. doi:10.1128/AAC.00292-1526195511
   PubMed Web of Science ®Google Scholar
• Hajjej Z, Gharsallah H, Naija H, et al. Successful treatment of a Carbapenem-resistant Klebsiella pneumoniae carrying blaOXA-48, blaVIM-2, blaCMY-2 and blaSHV-with high dose combination of imipenem and amikacin. IDCases. 2016;4:10–12. doi:10.1016/j.idcr.2016.01.00327051575
   PubMedGoogle Scholar
• Mansour W, Poirel L, Bettaieb D, et al. Dissemination of OXA-23–producing and carbapenem-resistant Acinetobacter baumannii in a University Hospital in Tunisia. Microb Drug Resist. 2008;14(4):289–292.19018672
   PubMed Web of Science ®Google Scholar
• Ktari S, Mnif B, Znazen A, et al. Diversity of β-lactamases in Pseudomonas aeruginosa isolates producing metallo-β-lactamase in two Tunisian hospitals. Microb Drug Resist. 2011;17(1):25–30. doi:10.1089/mdr.2010.010421190476
   PubMed Web of Science ®Google Scholar
• Hammami S, Boutiba-Ben Boubaker I, Ghozzi R, et al. Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit. Diagn Pathol. 2011;6:106. doi:10.1186/1746-1596-6-10622035284
   PubMed Web of Science ®Google Scholar
• Belotti P, Thabet L, Laffargue A, et al. Description of an original integron encompassing blaVIM-2, qnrVC1 and genes encoding bacterial group II intron proteins in Pseudomonas aeruginosa. J Antimicrob Chemother. 2015;70(8):2237–2240. doi:10.1093/jac/dkv10325977399
   PubMedGoogle Scholar
• Ben Helal R, Dziri R, Chedly M, et al. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae in a Tunisian Hospital. Microb Drug Resist. 2018;24(9):1361–1367.29596032
   PubMed Web of Science ®Google Scholar
• Jaidane N, Bonnin R, Mansour W, et al. Genomic insights into colistin-resistant Klebsiella pneumoniae from a Tunisian teaching hospital. Antimicrob Agents Chemother. 2018;62(2):pii=e01601–17.
   Web of Science ®Google Scholar
• Mansour W, Grami R, Jaidane N, et al. Epidemiology and Whole-Genome analysis of NDM-1-producing Klebsiella pneumoniae KP3771 from Tunisia. Microb Drug Resist. 2019;25(5):644–651. doi:10.1089/mdr.2018.020430614778
   PubMed Web of Science ®Google Scholar
• Hammami S, Dahdeh C, Mamlouk K, et al. Rectal carriage of extended-spectrum beta-lactamase and carbapenemase producing Gram-negative bacilli in intensive care units in Tunisia. Microb Drug Resist. 2017;23(6):695–702. doi:10.1089/mdr.2016.020528099062
   PubMed Web of Science ®Google Scholar
• Hamzaoui Z, Ocampo-Sosa A, Maamar E, et al. An outbreak of NDM-1-producing Klebsiella pneumoniae, associated with OmpK35 and OmpK36 porin loss in Tunisia. Microb Drug Resist. 2018;24(8):1137–1147. doi:10.1089/mdr.2017.016529373087
   PubMed Web of Science ®Google Scholar
• Maamar E, Alonso CA, Ferjani S, et al. NDM-1-and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia. Int J Antimicrob Agents. 2018;52(6):910–915.29665444
   PubMed Web of Science ®Google Scholar
• Ktari S, Mnif B, Louati F, et al. Spread of Klebsiella pneumoniae isolates producing OXA-48 β-lactamase in a Tunisian university hospital. J Antimicrob Chemother. 2011;66(7):1644–1646. doi:10.1093/jac/dkr18121565807
   PubMed Web of Science ®Google Scholar
• Lahlaoui H, Poirel L, Barguellil F, et al. Carbapenem-hydrolyzing class D β-lactamase OXA-48 in Klebsiella pneumoniae isolates from Tunisia. Eur J Clin Microbiol Infect Dis. 2012;31(6):937–939.21915739
   PubMed Web of Science ®Google Scholar
• Saïdani M, Hammami S, Kammoun A, et al. Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia. J Med Microbiol. 2012;61(12):1746–1749. doi:10.1099/jmm.0.045229-022918869
   PubMed Web of Science ®Google Scholar
• Mnif B, Ktari S, Chaari A, et al. Nosocomial dissemination of Providencia stuartii isolates carrying blaOXA-48, blaPER-1, blaCMY-4 and qnrA6 in a Tunisian hospital. J Antimicrob Chemother. 2013;68(2):329–332.23014719
   PubMed Web of Science ®Google Scholar
• Ouertani R, Ben Jomàa-Jemili M, Gharsa H, et al. Prevalence of a new variant OXA-204 and OXA-48 carbapenemases plasmids encoded in Klebsiella pneumoniae clinical isolates in Tunisia. Microb Drug Resist. 2018;24(2):142–149. doi:10.1089/mdr.2016.023628737463
   PubMed Web of Science ®Google Scholar
• Ben Tanfous F, Achour W, Raddaoui A, et al. Molecular characterisation and epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates from immunocompromised patients in Tunisia. J Glob Antimicrob Resist. 2018;13:154–160.29309948
   PubMed Web of Science ®Google Scholar
• Tanfous F, Raddaoui A, Chebbi Y, et al. Epidemiology and molecular characterisation of colistin-resistant Klebsiella pneumoniae isolates from immunocompromised patients in Tunisia. Int J Antimicrob Agents. 2018;52(6):861–865. doi:10.1016/j.ijantimicag.2018.08.02230176353
   PubMed Web of Science ®Google Scholar
• Ouertani R, Limelette A, Guillard T, et al. First report of nosocomial infection caused by Klebsiella pneumoniae ST147 producing OXA-48 and VEB-8 β-lactamases in Tunisia. J Glob Antimicrob Resist. 2016;4:53–56. doi:10.1016/j.jgar.2015.10.00227436394
   PubMed Web of Science ®Google Scholar
• Mathlouthi N, Al-Bayssari C, El Salabi A, et al. Carbapenemases and extended-spectrum β-lactamases producing Enterobacteriaceae isolated from Tunisian and Libyan hospitals. J Infect Dev Ctries. 2016;10(7):718–727. doi:10.3855/jidc.742627482803
   PubMed Web of Science ®Google Scholar
• Grami R, Mansour W, Ben Haj Khalifa A, et al. Emergence of ST147 Klebsiella pneumoniae producing OXA-204 carbapenemase in a University Hospital, Tunisia. Microb Drug Resist. 2016;22(2):137–140. doi:10.1089/mdr.2014.027826447939
   PubMed Web of Science ®Google Scholar
• Ktari S, Le Hello S, Ksibi B, et al. Carbapenemase-producing Salmonella enterica serotype Kentucky St198, North Africa. J Antimicrob Chemother. 2015;70(12):3405–3407.26377865
   PubMed Web of Science ®Google Scholar
• Mathlouthi N, Ben Lamine Y, Somai R, et al. Incidence of OXA-23 and OXA-58 carbapenemases coexpressed in clinical isolates of Acinetobacter baumannii in Tunisia. Microb Drug Resist. 2018;24(2):136–141. doi:10.1089/mdr.2016.030628691891
   PubMed Web of Science ®Google Scholar
• Hammami S, Ghozzi R, Saidani M, et al. Carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in Tunisia. Tunis Med. 2011;89(7):638–643.21780040
   PubMedGoogle Scholar
• Chihi H, Bonnin R, Bourouis A, et al. GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: long-term dissemination of GES-type carbapenemases in North Africa. J Glob Antimicrob Resist. 2016;5:47–50. doi:10.1016/j.jgar.2016.03.00527436466
   PubMed Web of Science ®Google Scholar
• Jaidane N, Naas T, Mansour W, et al. Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii. Int J Antimicrob Agents. 2018;51(2):266–269. doi:10.1016/j.ijantimicag.2017.10.01629127051
   PubMed Web of Science ®Google Scholar